BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011;2011:908407. [PMID: 21876803 DOI: 10.4061/2011/908407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Valavi E, Ahmadzadeh A, Amoori P, Daneshgar A. High Frequency of Acquired ADAMTS13 Deficiency After Hemolysis in Hemiscorpius Lepturus (Scorpion) Stung Children. Indian J Pediatr 2014;81:665-9. [DOI: 10.1007/s12098-013-1089-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Åkesson A, Zetterberg E, Klintman J. At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature: At the Cross Section of TMA and aHUS. Ther Apher Dial 2017;21:304-19. [DOI: 10.1111/1744-9987.12535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study. Pediatr Nephrol 2015;30:339-44. [PMID: 25138373 DOI: 10.1007/s00467-014-2911-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Cayci FS, Cakar N, Hancer VS, Uncu N, Acar B, Gur G. Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation. Pediatr Nephrol 2012;27:2327-31. [PMID: 22903728 DOI: 10.1007/s00467-012-2283-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
5 Lemaignen A, Ridel C, Hertig A, Rondeau E. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?]. Nephrol Ther 2013;9:129-36. [PMID: 23266201 DOI: 10.1016/j.nephro.2012.10.011] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Petruzziello-Pellegrini TN, Marsden PA. Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Curr Opin Nephrol Hypertens 2012;21:433-40. [PMID: 22660553 DOI: 10.1097/MNH.0b013e328354a62e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
7 Hamilton AJ, Lyons CB, Goodship TH, Bingham C. Prevalence in the General Population of a CFH Sequence Variant Associated with Atypical Haemolytic Uraemic Syndrome in an Extensive Family from Southwest England. Nephron Extra 2013;3:86-90. [PMID: 24163689 DOI: 10.1159/000354667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Vaterodt L, Holle J, Hüseman D, Müller D, Thumfart J. Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood. Front Pediatr 2018;6:220. [PMID: 30131950 DOI: 10.3389/fped.2018.00220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Vera-Aguilera J, Duma N, Gast K, Alkhateeb H, Tande A, Leung N, Hogan WJ, Kenderian SJ. Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient. Mayo Clin Proc Innov Qual Outcomes 2018;2:387-91. [PMID: 30560242 DOI: 10.1016/j.mayocpiqo.2018.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Singh D, Akingbola O, Yosypiv I, El-Dahr S. Emergency management of hypertension in children. Int J Nephrol 2012;2012:420247. [PMID: 22577545 DOI: 10.1155/2012/420247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Gitiaux C, Krug P, Grevent D, Kossorotoff M, Poncet S, Eisermann M, Oualha M, Boddaert N, Salomon R, Desguerre I. Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab. Dev Med Child Neurol 2013;55:758-65. [PMID: 23659643 DOI: 10.1111/dmcn.12161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
12 Kandasamy K, Jannatin M, Chen YC. Rapid Detection of Pathogenic Bacteria by the Naked Eye. Biosensors (Basel) 2021;11:317. [PMID: 34562907 DOI: 10.3390/bios11090317] [Reference Citation Analysis]
13 Shatzel JJ, Taylor JA. Syndromes of Thrombotic Microangiopathy. Med Clin North Am 2017;101:395-415. [PMID: 28189178 DOI: 10.1016/j.mcna.2016.09.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
14 Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell SC, Würzner R, Orth-Höller D. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Infect Immun 2013;81:2678-85. [PMID: 23690395 DOI: 10.1128/IAI.01079-12] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
15 Oualha M, Pierrepont S, Krug P, Gitiaux C, Hubert P, Lesage F, Salomon R. Postdiarrheal hemolytic and uremic syndrome with severe multiorgan involvement and associated early risk factors. Arch Pediatr 2018;25:118-25. [PMID: 29395881 DOI: 10.1016/j.arcped.2017.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Brunelli SM, Claxton A, Mehta S, Anum EA. Consequences of hemolytic uremic syndrome among hemodialysis patients. J Nephrol 2015;28:361-7. [PMID: 25491936 DOI: 10.1007/s40620-014-0149-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Sangeetha G, Jayaraj J, Ganesan S, Puttagunta S. Atypical haemolytic uraemic syndrome: a case of rare genetic mutation. BMJ Case Rep 2021;14:e244190. [PMID: 34330731 DOI: 10.1136/bcr-2021-244190] [Reference Citation Analysis]
18 Debernardi J, Pioche-Durieu C, Cam EL, Wiels J, Robert A. Verotoxin-1-Induced ER Stress Triggers Apoptotic or Survival Pathways in Burkitt Lymphoma Cells. Toxins (Basel) 2020;12:E316. [PMID: 32403276 DOI: 10.3390/toxins12050316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Burlaka I, Liu XL, Rebetz J, Arvidsson I, Yang L, Brismar H, Karpman D, Aperia A. Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL. J Am Soc Nephrol 2013;24:1413-23. [PMID: 23744887 DOI: 10.1681/ASN.2012101044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]